External sphincter spasticity syndrome in female patients.
The external sphincter spasticity syndrome is described with regard to diagnosis, etiology, pathophysiology and treatment. Use of urodynamic techniques (especially urethral pressure profile and diagnostic pudendal blocks) and adrenolytic agents and diazepam in the treatment of the dysfunction is discussed. We consider this clinical entity to be much more common than perviously reported.
D000328:Adult; D003975:Diazepam / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D013035:Spasm / Q000188:drug therapy; D013577:Syndrome; D014521:Urethra / Q000503:physiopathology; D014522:Urethral Diseases / Q000188:drug therapy / Q000503:physiopathology; D014555:Urination Disorders / Q000188:drug therapy / Q000503:physiopathology
D010643:Phenoxybenzamine; D008750:Methyldopa; D003975:Diazepam